Aim immunotech Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Aim immunotech Contact Number

Contact Us AIM Specialty Health

2 hours ago Aimspecialtyhealth.com Show details

800-252-2021Provider inquiries. For questions about a request or the ProviderPortal SM: Call 1-800-252-2021 or EMAIL OUR SUPPORT TEAM Business hours: 8:00 a.m. – 5:00 p.m. CST . Sales inquiries

Category: Contact SupportShow more

AIM ImmunoTech Crunchbase Company Profile & Funding

4 hours ago Crunchbase.com Show details

352 448 7797Phone Number +1 352 448 7797 AIM ImmunoTech is an immuno-pharmaceutical company based in Ocala, Florida. Its expertise is in the development of therapeutics for treating cancers and immune-deficiency disorders.

Founded: Jul 01, 2007
Location: Orlando, Florida

Category: Tech SupportShow more

Welcome AIM Specialty Health

1 hours ago Aimspecialtyhealth.com Show details

APPROPRIATE. SAFE. AFFORDABLE. At AIM Specialty Health ® (AIM), it’s our mission to promote appropriate, safe, and affordable health care. As the leading specialty benefits management partner for today’s health care organizations, we help improve the quality of care and reduce costs for today’s most complex tests and treatments.

Category: Contact NumberShow more

AIM ImmunoTech LinkedIn

2 hours ago Linkedin.com Show details

AIM ImmunoTech Inc., an immuno-pharma company headquartered in Ocala, Florida, is focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune

Category: Tech SupportShow more

AIM ImmunoTech Inc. 10K Mar. 30, 2021 7:52 PM Seeking Alpha

9 hours ago Seekingalpha.com Show details

(352) 448-7797Registrant’s telephone number, including area code: (352) 448-7797 AIM ImmunoTech Inc. and its subsidiaries (collectively, “AIM”, “Company”, “we” or “us”) are an immuno

Category: Tech SupportShow more

AIM ImmunoTech Inc. submits IND and Fast Track

9 hours ago Proactiveinvestors.com Show details

1 day ago · AIM ImmunoTech Inc said it has submitted an Investigational New Drug application (IND) and an accompanying application for Fast Track status with the US Food and Drug Administration (FDA) for a planned Phase 2 study of Ampligen as a therapy for locally advanced or metastatic late-stage pancreatic cancer.. The company said the planned AMP-270 clinical trial of around 250 subjects will …

Category: Tech SupportShow more

AIM ImmunoTech Receives Statistically Significant Positive

Just Now Bloomberg.com Show details

020-09-22CONTACT: Crescendo Communications, LLC Phone: 212-671-1021 Email: aim@crescendo-ir.com AIM ImmunoTech Inc Phone: 800-778-4042 Email: [email protected] SOURCE: AIM ImmunoTech Inc. View source

Category: Tech SupportShow more

AIM AIM ImmunoTech Inc Profile Reuters

7 hours ago Reuters.com Show details

AIM Immunotech Provides Clinical Updates On Planned Phase 2 Study Of Ampligen In Patients With Locally Advanced Or Metastatic Late-Stage Pancreatic Cancer Contact Info. 2117 SW Highway 484

Category: Tech SupportShow more

AIM ImmunoTech Submits IND and Accompanying Fast Track

2 hours ago Stockhouse.com Show details

OCALA, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has submitted an Investigational New Drug application (IND) and an accompanying application for Fast Track status with the U.S. Food and Drug Administration (FDA) for a planned Phase 2 study of the company’s drug Ampligen as a therapy for locally …

Category: Tech SupportShow more

AIM ImmunoTech Submits IND and Accompanying Fast Track

5 hours ago Finance.yahoo.com Show details

1 day ago · AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19

Category: Tech SupportShow more

Is AIM ImmunoTech Inc (AIM) A Winner in the Healthcare Sector?

1 hours ago Investorsobserver.com Show details

AIM ImmunoTech Inc (AIM) stock is down -6.83% while the S&P 500 has risen 0.05% as of 10:33 AM on Tuesday, Jun 2. AIM is lower by -$0.19 from the previous closing price of $2.78 on volume of 892,337 shares. Over the past year the S&P 500 is up 11.40% while AIM is lower by -45.47%. AIM lost -$2.55 per share the over the last 12 months. To screen

Category: Tech SupportShow more

AIM ImmunoTech Submits PreIND Application to the FDA for

6 hours ago Finance.yahoo.com Show details

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19

Category: Tech SupportShow more

AIM ImmunoTech Submits IND and Accompanying Fast Track

8 hours ago Tmcnet.com Show details

1 day ago · OCALA, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has submitted an Investigational New Drug application (IND) and an accompanying application for Fast Track status with the U.S. Food and Drug Administration (FDA) for a planned Phase 2 study of the company’s drug Ampligen as a therapy for locally advanced or …

Category: Tech SupportShow more

AIM ImmunoTech Wikipedia

Just Now En.wikipedia.org Show details

AIM ImmunoTech Inc. ( AMEX : AIM ), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has 23 employees.

Category: Tech SupportShow more

AIM ImmunoTech Reports 2020 YearEnd Financial Results

2 hours ago Nasdaq.com Show details

021-03-31Investor Relations Contact: Crescendo Communications, LLC Phone: 212-671-1021Email: aim@crescendo-ir.com AIM ImmunoTech Inc Phone: 800-778-4042Email: [email protected] AIM ImmunoTech Inc.

Category: Tech SupportShow more

AIM ImmunoTech Inc. (Form: 10Q, Received: 08/16/2021 16

2 hours ago Marketwatch.com Show details

Commission File Number: 001-27072 AIM IMMUNOTECH INC. (Exact name of registrant as specified in its charter)

Category: Tech SupportShow more

AIM ImmunoTech Inc. (AMEX:AIM) Currently 56.12% Below Its

1 hours ago Marketingsentinel.com Show details

AIM ImmunoTech Inc.’s shares saw a change of 9.50% in year-to-date performance and have moved -4.39% in past 5-day. AIM ImmunoTech Inc. (AMEX:AIM) showed a performance of -5.77% in past 30-days. Number of shares sold short was 0.99 million shares which calculate 1.86 days to cover the short interests.

Category: Tech SupportShow more

AIM AIM ImmunoTech Inc. Stock Price & News WSJ

2 hours ago Wsj.com Show details

News AIM ImmunoTech Inc.AIM. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per

Category: Tech SupportShow more

AIM ImmunoTech Inc (AIM) Down 2.42% in Premarket Trading

5 hours ago Investorsobserver.com Show details

AIM ImmunoTech Inc has a Long-Term Technical rank of 22. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 78% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, AIM ranks better than 45% of stocks. Important Dates for Investors in AIM:

Category: Tech SupportShow more

Ampligen in Chronic Fatigue Syndrome Full Text View

7 hours ago Clinicaltrials.gov Show details

AIM ImmunoTech Inc. ClinicalTrials.gov Identifier: NCT00215813 Other Study ID Numbers: AMP 511 : First Posted: September 22, 2005 Key Record Dates: Last Update Posted: April 8, 2021 Last Verified: April 2021

Category: Contact NumberShow more

AIM ImmunoTech CEO Thomas K. Equels Participates in

6 hours ago Ca.finance.yahoo.com Show details

OCALA, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces that Thomas K. Equels, CEO of AIM ImmunoTech, participated in a ‘Fireside Chat’ video interview with Ed Woo, Director of Research & Senior Analyst at Ascendiant Capital Markets. During the Fireside Chat, Equels discusses recent accomplishments, key upcoming goals and …

Category: Tech SupportShow more

AIM Yahoo Search Results

3 hours ago Search.yahoo.com Show details

AIM is the first 501 (c) (3) non-profit organization in the Washington, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of ability to pay. Integrative medicine combines conventional medical care with complementary medicine.

Category: Contact NumberShow more

AIM ImmunoTech CEO Thomas K. Equels Participates in

5 hours ago Ca.sports.yahoo.com Show details

212-671-1021Investor Relations Contact: Crescendo Communications, LLC Phone: 212-671-1021 Email: aim@crescendo-ir.com. AIM ImmunoTech Inc Phone: 800-778-4042 Email: [email protected]

Category: Tech SupportShow more

AIM: Average Analyst Price Target is $6.33

5 hours ago Stocknews.com Show details

AIM ImmunoTech Inc's upside potential (average analyst target price relative to current price) is higher than 91.85% of all US stocks. AIM has a greater average analyst price target than 11.61% of all US stocks. AIM has a greater number of analysts covering the …

Category: Contact NumberShow more

AIM ImmunoTech Inc. Common Stock (AIM) Insider Activity

3 hours ago Nasdaq.com Show details

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is …

Category: Tech SupportShow more

AIM ImmunoTech Inc. 10Q Aug. 14, 2020 5:03 PM Seeking Alpha

9 hours ago Seekingalpha.com Show details

Commission File Number: 001-27072 . AIM IMMUNOTECH INC. (Exact name of registrant as specified in its charter) Delaware : 52-0845822 (State or other jurisdiction of (I.R.S. Employer:

Category: Tech SupportShow more

Aspirin and Rintatolimod With or Without Interferonalpha

7 hours ago Clinicaltrials.gov Show details

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03899987

Category: Contact NumberShow more

SRO List Food and Drug Administration

3 hours ago Accessdata.fda.gov Show details

DUNS NUMBER BUSINESS NAME COUNTRY NAME TICKER SYMBOL EXCHANGE NAME; 057015198 : Soliton Inc : USA : SOLY : NASDAQ : 057383762 : Coffee Holding Co., Inc. USA

Category: Contact NumberShow more

Hemispherx Biopharma Inc's Ampligen treatment aims to

3 hours ago Proactiveinvestors.com Show details

view AIM ImmunoTech Inc Hemispherx Biopharma’s Ampligen treatment aims to disrupt the cancer market CEO Tom Equels says Ampligen on a standalone basis has demonstrated effects in 'a number of solid tumors'

Category: Contact NumberShow more

AIM ImmunoTech Receives Statistically Significant Positive

1 hours ago Accesswire.com Show details

Median survival approximately two-fold higher in Ampligen arm compared to historical controls; AIM to seek FDA Fast Track designation and orphan drug status in late stage pancreatic cancer OCALA, FL / ACCESSWIRE / September 22, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced receipt of statistically significant positive pancreatic cancer survival results from a multi …

Category: Tech SupportShow more

AIM ImmunoTech Files Provisional Patent Application for

3 hours ago Benzinga.com Show details

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19

Category: Tech SupportShow more

BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as

4 hours ago Ca.finance.yahoo.com Show details

Thomas K. Equels CEO of AIM ImmunoTech Inc.TAMPA, Fla. and OCALA, Fla., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioFlorida has announced Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech Inc. (NYSE American: AIM), as its Weaver H. Gaines Entrepreneur of the Year. The Entrepreneur of the Year Award recognizes an entrepreneur who has made extraordinary …

Category: Tech SupportShow more

Equels (’80) Leads Team Testing Potential COVID19

6 hours ago Law.fsu.edu Show details

Tallahassee—Thomas K. Equels is the president and CEO of AIM ImmunoTech, where he leads a team of immunology research and development professionals dedicated to the clinical development of new drug entities for the treatment of serious and debilitating diseases.The company recently announced that Japan’s National Institute of Infectious Diseases will be testing its flagship …

Category: Contact NumberShow more

Adam Barnes Test Engineer eConsult Health LinkedIn

8 hours ago Uk.linkedin.com Show details

View Adam Barnes’ profile on LinkedIn, the world’s largest professional community. Adam has 8 jobs listed on their profile. See the complete profile on LinkedIn and discover Adam’s connections and jobs at similar companies.

Title: Test Engineer at eConsult Health
Location: Crawley, England, United Kingdom
Connections: 239

Category: Contact NumberShow more

In the Coronavirus Vaccine Race, AIM Stock Isn't a Likely

1 hours ago Investorplace.com Show details

A number of biotech and pharmaceutical stocks have rallied sharply on hopes they can be part of the response to the coronavirus pandemic. Nano-cap AIM ImmunoTech (NYSEAMERICAN: AIM) stock has been

Category: Contact NumberShow more

USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

Just Now Ttabvue.uspto.gov Show details

Summary. Query: Correspondence Name contains all words: DONNA J. BUNTON Number of results: 100+ Results are in reverse chronological order

Category: Contact NumberShow more

SRO List Food and Drug Administration

2 hours ago Accessdata.fda.gov Show details

3. SRO List. -. You can search the list by entering the DUNS NUMBER, BUSINESS NAME, or TICKER SYMBOL in the search criteria. The SRO list is a comprehensive and important resource to check regularly, however, it is not definitive. There are some situations where a financial interest may constitute a prohibited financial interest in an SRO, even

Category: Contact NumberShow more

AIM ImmunoTech Added to Russell Microcap(R) Index

1 hours ago Accesswire.com Show details

OCALA, FL / ACCESSWIRE / June 29, 2020 / AIM ImmunoTech (NYSE American:AIM), today announced that it has been added to the Russell Microcap® Index, following the annual Russell indexes reconstitution, effective after the market open on June 29, according to a final list of additions posted on June 26. Annual Russell indexes reconstitution captures the 4,000 largest US stocks, …

Category: Tech SupportShow more

AIM ImmunoTech Files Provisional Patent Application for

2 hours ago Ca.movies.yahoo.com Show details

OCALA, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of a provisional patent application for Ampligen as a potential early-onset intranasal therapy designed to enhance and expand infection-induced immunity, epitope spreading, cross-reactivity and cross-protection in patients exposed to a wide range of RNA …

Category: Tech SupportShow more

AIM Stock quote for AIM ImmunoTech Inc. MSN Money

4 hours ago Msn.com Show details

View the latest AIM stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of AIM ImmunoTech Inc..

Category: Tech SupportShow more

AIM ImmunoTech Completes and Closes ATM Facility; Current

3 hours ago Apnews.com Show details

About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Category: Tech SupportShow more

AIM Stock Price AIM ImmunoTech Inc. Stock Quote (U.S

7 hours ago Marketwatch.com Show details

AIM ImmunoTech stock price target raised to $6.50 from $2.75 at Alliance Global Partners. Mar. 10, 2020 at 8:14 a.m. ET by Tomi Kilgore.

Category: Tech SupportShow more

AIM ImmunoTech Provides Clinical Updates on Planned Phase

1 hours ago Apnews.com Show details

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Category: Tech SupportShow more

USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

9 hours ago Ttabvue.uspto.gov Show details

Summary. Query: Correspondence Name contains all words: DONNA J BUNTON Number of results: 100+ Results are in reverse chronological order

Category: Contact NumberShow more

AIM ImmunoTech Announces Filing of Provisional Patent

3 hours ago Tmcnet.com Show details

OCALA, Fla., Aug. 25, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today provided an update on the company’s efforts to develop its drug Ampligen as a potential intranasal therapeutic for COVID-19, including the announcement of a new provisional patent application for Ampligen as both an intranasal and an intravenous therapy for what AIM describes as …

Category: Tech SupportShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is aim Immunotech?

Visit a quote page and your recently viewed tickers will be displayed here. AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders.

How to contact aim specialty health by phone?

For questions about a request or the ProviderPortalSM: For questions about our solutions and how they can support your organization: For faster service and answers to questions about a specific case, please use the dedicated phone number on your patient’s health plan membership card.

Which is an update to the Triple Aim?

An update to the Triple Aim, the Quadruple Aim is an ambitious industry framework for your organization to follow for success. The key? Turning its vision into a to-do list.

Popular Brands

Amazon
Abbvie
Aia
Asml
Att
Amgen
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes